(E)-ETHYL 3-(1-METHYL-1H-PYRAZOL-4-YL)ACRYLATE, 95.0%, 1g

Tazarotenic acid, 99.57%, 5mg

3-Methoxy-2,2-dimethyl-3-oxopropanoic acid, 95.0%, 1g

3-Ethoxy-4-hydroxyphenylacetic acid, 97.0%, 5g

(E)-N-(3-METHOXYPHENYL)-3-PHENYL-2-PROPENAMIDE, 95.0%, 5g

(4-(pyridin-3-yloxy)phenyl)methanol, 95.0%, 500mg

10-((tert-Butoxycarbonyl)amino)decanoic acid, 95.0%, 10g

(4-{[4-(1H-benzimidazol-2-yl)piperidin-1-yl]sulfonyl}phenyl)amine, 95.0%, 500mg

1-N-Boc-3-Carbamoylpiperidine, 95.0%, 5g

tert-Butyl 2-oxo-8'-azaspiro[azetidine-3,3'-bicyclo[3.2.1]octane]-8'-carboxylate, 97%, 50mg

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-1,8-naphthyridin-2(1H)-one, 98%, 5g

2-Bromo-3-fluoro-6-methyl-4-nitroaniline, 98.0%, 1g

2-(Methylthio)benzoxazole>98.0%(GC)1g